Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 4 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Related structures:
AlphaFold database: A0A3S5H6A9
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0030030 | cell projection organization | 4 | 1 |
GO:0044782 | cilium organization | 5 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 14 |
GO:0005509 | calcium ion binding | 5 | 14 |
GO:0043167 | ion binding | 2 | 14 |
GO:0043169 | cation binding | 3 | 14 |
GO:0046872 | metal ion binding | 4 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 168 | 172 | PF00656 | 0.761 |
CLV_C14_Caspase3-7 | 292 | 296 | PF00656 | 0.698 |
CLV_C14_Caspase3-7 | 375 | 379 | PF00656 | 0.521 |
CLV_C14_Caspase3-7 | 45 | 49 | PF00656 | 0.663 |
CLV_C14_Caspase3-7 | 473 | 477 | PF00656 | 0.736 |
CLV_C14_Caspase3-7 | 543 | 547 | PF00656 | 0.520 |
CLV_NRD_NRD_1 | 152 | 154 | PF00675 | 0.724 |
CLV_NRD_NRD_1 | 261 | 263 | PF00675 | 0.532 |
CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.658 |
CLV_NRD_NRD_1 | 352 | 354 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 368 | 370 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 474 | 476 | PF00675 | 0.506 |
CLV_NRD_NRD_1 | 521 | 523 | PF00675 | 0.545 |
CLV_PCSK_KEX2_1 | 152 | 154 | PF00082 | 0.724 |
CLV_PCSK_KEX2_1 | 368 | 370 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 395 | 397 | PF00082 | 0.604 |
CLV_PCSK_KEX2_1 | 474 | 476 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 521 | 523 | PF00082 | 0.627 |
CLV_PCSK_PC1ET2_1 | 395 | 397 | PF00082 | 0.606 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 508 | 512 | PF00082 | 0.570 |
DEG_APCC_DBOX_1 | 23 | 31 | PF00400 | 0.594 |
DEG_APCC_DBOX_1 | 352 | 360 | PF00400 | 0.530 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.472 |
DEG_SCF_FBW7_1 | 121 | 128 | PF00400 | 0.811 |
DEG_SPOP_SBC_1 | 131 | 135 | PF00917 | 0.749 |
DOC_CYCLIN_yClb1_LxF_4 | 12 | 17 | PF00134 | 0.566 |
DOC_PP1_RVXF_1 | 12 | 18 | PF00149 | 0.456 |
DOC_PP1_RVXF_1 | 177 | 183 | PF00149 | 0.361 |
DOC_USP7_MATH_1 | 119 | 123 | PF00917 | 0.746 |
DOC_USP7_MATH_1 | 125 | 129 | PF00917 | 0.656 |
DOC_USP7_MATH_1 | 130 | 134 | PF00917 | 0.688 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.724 |
DOC_USP7_MATH_1 | 272 | 276 | PF00917 | 0.619 |
DOC_USP7_MATH_1 | 282 | 286 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 360 | 364 | PF00917 | 0.576 |
DOC_USP7_MATH_1 | 372 | 376 | PF00917 | 0.565 |
DOC_USP7_MATH_1 | 571 | 575 | PF00917 | 0.665 |
DOC_USP7_UBL2_3 | 350 | 354 | PF12436 | 0.656 |
DOC_USP7_UBL2_3 | 488 | 492 | PF12436 | 0.464 |
DOC_USP7_UBL2_3 | 96 | 100 | PF12436 | 0.609 |
DOC_WW_Pin1_4 | 121 | 126 | PF00397 | 0.805 |
DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.698 |
LIG_14-3-3_CanoR_1 | 129 | 138 | PF00244 | 0.806 |
LIG_14-3-3_CanoR_1 | 152 | 156 | PF00244 | 0.684 |
LIG_14-3-3_CanoR_1 | 228 | 237 | PF00244 | 0.432 |
LIG_14-3-3_CanoR_1 | 32 | 38 | PF00244 | 0.620 |
LIG_APCC_ABBA_1 | 60 | 65 | PF00400 | 0.472 |
LIG_APCC_ABBAyCdc20_2 | 59 | 65 | PF00400 | 0.438 |
LIG_BIR_III_2 | 171 | 175 | PF00653 | 0.642 |
LIG_BRCT_BRCA1_1 | 251 | 255 | PF00533 | 0.437 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.817 |
LIG_FHA_1 | 160 | 166 | PF00498 | 0.797 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.398 |
LIG_FHA_1 | 243 | 249 | PF00498 | 0.400 |
LIG_FHA_1 | 52 | 58 | PF00498 | 0.529 |
LIG_FHA_2 | 211 | 217 | PF00498 | 0.390 |
LIG_FHA_2 | 230 | 236 | PF00498 | 0.429 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.537 |
LIG_FHA_2 | 526 | 532 | PF00498 | 0.581 |
LIG_LIR_Gen_1 | 230 | 238 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 68 | 74 | PF02991 | 0.548 |
LIG_LIR_Gen_1 | 80 | 90 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 230 | 234 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 235 | 240 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.544 |
LIG_LIR_Nem_3 | 80 | 85 | PF02991 | 0.427 |
LIG_LYPXL_S_1 | 240 | 244 | PF13949 | 0.437 |
LIG_LYPXL_yS_3 | 241 | 244 | PF13949 | 0.417 |
LIG_Pex14_2 | 17 | 21 | PF04695 | 0.441 |
LIG_Pex14_2 | 198 | 202 | PF04695 | 0.432 |
LIG_RPA_C_Fungi | 481 | 493 | PF08784 | 0.593 |
LIG_SH2_CRK | 82 | 86 | PF00017 | 0.486 |
LIG_SH2_STAT3 | 86 | 89 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.770 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.554 |
LIG_SH2_STAT5 | 249 | 252 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 562 | 565 | PF00017 | 0.685 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.472 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.478 |
LIG_SH3_3 | 87 | 93 | PF00018 | 0.524 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.577 |
LIG_Sin3_3 | 370 | 377 | PF02671 | 0.678 |
LIG_SUMO_SIM_par_1 | 190 | 197 | PF11976 | 0.420 |
LIG_TRAF2_1 | 173 | 176 | PF00917 | 0.535 |
LIG_TRAF2_1 | 26 | 29 | PF00917 | 0.491 |
MOD_CDK_SPxxK_3 | 170 | 177 | PF00069 | 0.675 |
MOD_CK1_1 | 210 | 216 | PF00069 | 0.388 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.563 |
MOD_CK1_1 | 275 | 281 | PF00069 | 0.608 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.502 |
MOD_CK1_1 | 557 | 563 | PF00069 | 0.543 |
MOD_CK2_1 | 170 | 176 | PF00069 | 0.589 |
MOD_CK2_1 | 227 | 233 | PF00069 | 0.379 |
MOD_CK2_1 | 23 | 29 | PF00069 | 0.512 |
MOD_CK2_1 | 264 | 270 | PF00069 | 0.578 |
MOD_CK2_1 | 525 | 531 | PF00069 | 0.516 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.773 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.777 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.418 |
MOD_GlcNHglycan | 297 | 300 | PF01048 | 0.589 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.562 |
MOD_GlcNHglycan | 458 | 461 | PF01048 | 0.539 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.649 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.754 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.753 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.710 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.564 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.623 |
MOD_GSK3_1 | 550 | 557 | PF00069 | 0.542 |
MOD_GSK3_1 | 569 | 576 | PF00069 | 0.588 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.882 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.896 |
MOD_NEK2_1 | 207 | 212 | PF00069 | 0.417 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.620 |
MOD_NEK2_2 | 51 | 56 | PF00069 | 0.629 |
MOD_PIKK_1 | 525 | 531 | PF00454 | 0.516 |
MOD_PIKK_1 | 95 | 101 | PF00454 | 0.593 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.704 |
MOD_PKA_2 | 227 | 233 | PF00069 | 0.432 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.529 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.557 |
MOD_PKA_2 | 360 | 366 | PF00069 | 0.610 |
MOD_PKA_2 | 544 | 550 | PF00069 | 0.526 |
MOD_Plk_1 | 275 | 281 | PF00069 | 0.653 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.518 |
MOD_Plk_1 | 530 | 536 | PF00069 | 0.639 |
MOD_Plk_2-3 | 264 | 270 | PF00069 | 0.466 |
MOD_ProDKin_1 | 121 | 127 | PF00069 | 0.805 |
MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.693 |
MOD_SUMO_for_1 | 434 | 437 | PF00179 | 0.651 |
MOD_SUMO_rev_2 | 171 | 178 | PF00179 | 0.513 |
MOD_SUMO_rev_2 | 183 | 190 | PF00179 | 0.348 |
MOD_SUMO_rev_2 | 375 | 384 | PF00179 | 0.584 |
MOD_SUMO_rev_2 | 392 | 397 | PF00179 | 0.614 |
MOD_SUMO_rev_2 | 546 | 556 | PF00179 | 0.538 |
MOD_SUMO_rev_2 | 64 | 68 | PF00179 | 0.556 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.441 |
TRG_ENDOCYTIC_2 | 241 | 244 | PF00928 | 0.439 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.488 |
TRG_ER_diArg_1 | 151 | 153 | PF00400 | 0.754 |
TRG_ER_diArg_1 | 521 | 524 | PF00400 | 0.629 |
TRG_ER_diArg_1 | 539 | 542 | PF00400 | 0.400 |
TRG_Pf-PMV_PEXEL_1 | 315 | 320 | PF00026 | 0.524 |
TRG_Pf-PMV_PEXEL_1 | 508 | 512 | PF00026 | 0.557 |
TRG_Pf-PMV_PEXEL_1 | 524 | 529 | PF00026 | 0.439 |
TRG_Pf-PMV_PEXEL_1 | 532 | 536 | PF00026 | 0.480 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1II86 | Leptomonas seymouri | 83% | 99% |
A0A0S4JFD7 | Bodo saltans | 33% | 95% |
A0A0S4JWH7 | Bodo saltans | 51% | 98% |
A0A0S4KKB4 | Bodo saltans | 23% | 85% |
A0A1X0NMV7 | Trypanosomatidae | 58% | 98% |
A0A3S7X1F4 | Leishmania donovani | 23% | 100% |
A0A422NE50 | Trypanosoma rangeli | 56% | 100% |
A4H5I7 | Leishmania braziliensis | 92% | 100% |
A4HGH2 | Leishmania braziliensis | 25% | 98% |
A4HTS8 | Leishmania infantum | 100% | 100% |
A4I3K4 | Leishmania infantum | 23% | 99% |
D0A836 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 22% | 100% |
D0A989 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 99% |
E9AML1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
E9AZU4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
Q4Q8E1 | Leishmania major | 24% | 100% |
Q4QI25 | Leishmania major | 99% | 100% |
V5DJB6 | Trypanosoma cruzi | 57% | 90% |